Genetic Technologies Pb Ratio Over Time
| GENE Stock | USD 0.77 0.00 0.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Genetic Technologies Performance and Genetic Technologies Correlation. Genetic |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genetic Technologies. If investors know Genetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genetic Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 2.19 | Quarterly Revenue Growth (0.11) | Return On Assets (0.63) | Return On Equity (1.85) |
The market value of Genetic Technologies is measured differently than its book value, which is the value of Genetic that is recorded on the company's balance sheet. Investors also form their own opinion of Genetic Technologies' value that differs from its market value or its book value, called intrinsic value, which is Genetic Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genetic Technologies' market value can be influenced by many factors that don't directly affect Genetic Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genetic Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Genetic Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genetic Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Pb Ratio Analysis
Compare Genetic Technologies and related stocks such as Fonar, Burning Rock Biotech, and Sera Prognostics Pb Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FONR | (15.814) | 4.8577 | 2.7311 | 2.9581 | 1.7017 | 2.5007 | 2.3451 | 1.6917 | 1.1928 | 1.1092 | 0.8445 | 0.6732 | 0.7197 | 0.6176 | 0.59 |
| BNR | 781 | 781 | 781 | 781 | 781 | 781 | 781 | 781 | (62.7987) | (167) | 42.7306 | 34.1854 | 13.921 | 0.9165 | 0.87 |
| SERA | (3.4262) | (3.4262) | (3.4262) | (3.4262) | (3.4262) | (3.4262) | (3.4262) | (3.4262) | (3.4262) | (3.4262) | (2.9093) | 1.5258 | 0.3941 | 2.6594 | 2.79 |
| XGN | 0.1364 | 0.1364 | 0.1364 | 2.2113 | (0.0745) | (0.0526) | (0.2524) | (0.2524) | (0.1738) | 5.7322 | 3.9917 | 2.187 | 0.9656 | 1.5503 | 1.18 |
| SHC | 139 | 139 | 139 | 139 | 139 | 139 | 139 | 139 | 139 | (11.11) | 17.098 | 11.2197 | 6.6618 | 10.6708 | 10.14 |
| DRIO | (0.7569) | (0.7569) | (0.7569) | (8.5933) | (0.693) | 8.9099 | (2.5852) | 3.9138 | 2.0357 | 0.7868 | 3.0271 | 2.5155 | 1.2645 | 0.8393 | 0.71 |
| STIM | (0.0018) | (0.0018) | (0.0018) | (0.0018) | (0.0018) | (0.0018) | (0.0018) | (0.0016) | 2.4372 | 1.7246 | 8.2084 | 1.3342 | 3.2387 | 2.4308 | 1.94 |
| MDXH | 0.6393 | 1.4074 | 1.6528 | 1.469 | 1.7543 | 1.119 | 1.0483 | 1.3755 | 1.3265 | 3.8073 | 17.0694 | 2.4752 | 11.2585 | 14.1632 | 14.87 |
Genetic Technologies and related stocks such as Fonar, Burning Rock Biotech, and Sera Prognostics Pb Ratio description
My Equities
My Current Equities and Potential Positions
| Genetic Technologies | GENE |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Australia |
| Exchange | NASDAQ Exchange |
USD 0.77
Check out Genetic Technologies Performance and Genetic Technologies Correlation. For information on how to trade Genetic Stock refer to our How to Trade Genetic Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Genetic Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.